Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids-Reference-Cited by-同舟云学术

Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids

Published:2022-02-08 Issue:6 Volume:76 Page:1617-1633
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Ruiz de Gauna Mikel,Biancaniello Francesca,González‐Romero Francisco,Rodrigues Pedro M.,Lapitz Ainhoa,Gómez‐Santos Beatriz,Olaizola Paula,Di Matteo Sabina,Aurrekoetxea Igor,Labiano Ibone,Nieva‐Zuluaga Ane,Benito‐Vicente Asier,Perugorria María J.,Apodaka‐Biguri Maider,Paiva Nuno A.,Sáenz de Urturi Diego,Buqué Xabier,Delgado Igotz,Martín César,Azkargorta Mikel,Elortza Felix,Calvisi Diego F.,Andersen Jesper B.,Alvaro Domenico,Cardinale Vincenzo,Bujanda Luis,Banales Jesús M.,Aspichueta Patricia

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32344

Reference49 articles.

1. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS‐CCA);Nat Rev Gastroenterol Hepatol,2016

2. Cholangiocarcinoma 2020: the next horizon in mechanisms and management;Nat Rev Gastroenterol Hepatol,2020

3. Pathologic classification of cholangiocarcinoma: new concepts;Best Pract Res Clin Gastroenterol,2015

4. Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type;J Hepatobiliary Pancreat Sci,2015

5. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta‐analysis;J Hepatol,2020

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered fatty acid metabolism rewires cholangiocarcinoma stemness features;JHEP Reports;2024-08

2. The effect of genetics and biochemistry on the pathogenesis of cholangiocarcinoma;International Journal of Hepatobiliary and Pancreatic Diseases;2024-07-25

3. The Tumor Immune Microenvironment plays a Key Role in Driving the Progression of Cholangiocarcinoma;Current Cancer Drug Targets;2024-07

4. MAL2 reprograms lipid metabolism in intrahepatic cholangiocarcinoma via EGFR/SREBP-1 pathway based on single-cell RNA sequencing;Cell Death & Disease;2024-06-12

5. Role of lipid metabolism in hepatocellular carcinoma;Discover Oncology;2024-06-04